MAPT and Alzheimer disease: Additionally, several studies have demonstrated the effectiveness of rapamycin on ameliorating neuropathology in mouse AD models overexpressing amyloid beta or hyperphosphorylated Tau (Lin et al., 2013; Ozcelik et al., 2013; Siman et al., 2015; Spilman et al., 2010).